Boston Research & Management Inc Laboratory Corp Of America Holdings Transaction History

Boston Research & Management Inc

$426 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$209.01 - $232.56 $70,645 - $78,605	338 Added 1.4%	24,467 $5.35 Million
Q4 2023 Feb 12, 2024	BUY	$197.69 - $227.29 $227,541 - $261,610	1,151 Added 5.01%	24,129 $5.48 Million
Q3 2023 Nov 13, 2023	BUY	$201.05 - $221.7 $113,995 - $125,703	567 Added 2.53%	22,978 $4.62 Million
Q2 2023 Aug 01, 2023	SELL	$211.93 - $241.33 $5,510 - $6,274	-26 Reduced 0.12%	22,411 $5.41 Million
Q1 2023 May 10, 2023	BUY	$213.32 - $257.83 $60,796 - $73,481	285 Added 1.29%	22,437 $5.15 Million
Q4 2022 Feb 13, 2023	SELL	$203.72 - $248.97 $28,520 - $34,855	-140 Reduced 0.63%	22,152 $5.22 Million
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $88,887 - $113,790	434 Added 1.99%	22,292 $4.57 Million
Q2 2022 Aug 11, 2022	BUY	$213.86 - $277.87 $124,466 - $161,720	582 Added 2.74%	21,858 $5.12 Million
Q1 2022 May 12, 2022	SELL	$259.82 - $298.18 $110,943 - $127,322	-427 Reduced 1.97%	21,276 $5.61 Million
Q4 2021 Feb 10, 2022	SELL	$271.6 - $314.21 $28,518 - $32,992	-105 Reduced 0.48%	21,703 $6.82 Million
Q3 2021 Nov 10, 2021	SELL	$274.82 - $308.34 $108,004 - $121,177	-393 Reduced 1.77%	21,808 $6.14 Million
Q3 2021 Nov 10, 2021	BUY	$274.82 - $308.34 $20,886 - $23,433	76 Added 0.34%	22,201 $5.66 Million
Q2 2021 Aug 11, 2021	SELL	$251.87 - $278.14 $19,142 - $21,138	-76 Reduced 0.34%	22,125 $6.1 Million
Q1 2021 May 11, 2021	SELL	$204.88 - $255.03 $64,127 - $79,824	-313 Reduced 1.39%	22,201 $5.66 Million
Q4 2020 Feb 09, 2021	BUY	$186.91 - $214.42 $42,802 - $49,102	229 Added 1.03%	22,514 $4.58 Million
Q3 2020 Nov 09, 2020	SELL	$167.03 - $201.3 $150,828 - $181,773	-903 Reduced 3.89%	22,285 $4.2 Million
Q2 2020 Aug 10, 2020	SELL	$113.31 - $182.44 $793 - $1,277	-7 Reduced 0.03%	23,188 $3.85 Million
Q1 2020 May 08, 2020	SELL	$104.32 - $195.28 $77,301 - $144,702	-741 Reduced 3.1%	23,195 $2.93 Million
Q4 2019 Feb 07, 2020	BUY	$163.48 - $173.61 $31,061 - $32,985	190 Added 0.8%	23,936 $4.05 Million
Q3 2019 Nov 12, 2019	BUY	$159.77 - $178.1 $115,034 - $128,232	720 Added 3.13%	23,746 $3.99 Million
Q2 2019 Aug 07, 2019	SELL	$144.16 - $172.9 $10,812 - $12,967	-75 Reduced 0.32%	23,026 $3.98 Million
Q1 2019 May 07, 2019	BUY	$123.7 - $156.3 $194,209 - $245,391	1,570 Added 7.29%	23,101 $3.53 Million
Q4 2018 Feb 06, 2019	SELL	$120.82 - $174.09 $39,870 - $57,449	-330 Reduced 1.51%	21,531 $2.72 Million
Q3 2018 Nov 13, 2018	BUY	$167.67 - $188.27 $16,767 - $18,827	100 Added 0.46%	21,861 $3.8 Million
Q2 2018 Jul 30, 2018	SELL	$160.33 - $189.41 $104,214 - $123,116	-650 Reduced 2.9%	21,761 $3.91 Million
Q1 2018 May 09, 2018	SELL	$161.53 - $178.11 $4,845 - $5,343	-30 Reduced 0.13%	22,411 $3.62 Million
Q4 2017 Feb 09, 2018	SELL	$147.99 - $163.95 $115,432 - $127,880	-780 Reduced 3.36%	22,441 $3.58 Million
Q3 2017 Nov 09, 2017	BUY	$149.47 - $160.56 $3.47 Million - $3.73 Million	23,221	23,221 $3.51 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Research & Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Boston Research & Management Inc with notifications on news.

Account